According to Kura Oncology 's latest financial reports the company's current EPS (TTM) is -1,81 โฌ. In 2022 the company made an earnings per share (EPS) of -1,79 โฌ a decrease over its 2021 EPS that were of -1,73 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -1,94 โฌ | 8.31% |
2022 | -1,79 โฌ | 3.57% |
2021 | -1,73 โฌ | 15.98% |
2020 | -1,49 โฌ | 12.67% |
2019 | -1,32 โฌ | -13.29% |
2018 | -1,53 โฌ | 12.34% |
2017 | -1,36 โฌ | 4.76% |
2016 | -1,30 โฌ | -50% |
2015 | -2,60 โฌ |